Previous close | 1.4000 |
Open | 1.0900 |
Bid | 1.2100 |
Ask | 1.4100 |
Strike | 17.50 |
Expiry date | 2025-01-17 |
Day's range | 1.0900 - 1.3200 |
Contract range | N/A |
Volume | |
Open interest | 24.99k |
Walgreens Boots Alliance (WBA) posted its second report, revealing a quarterly revenue that beat expectations but a narrow outlook for 2024, citing difficult conditions within the retail environment. Jefferies Healthcare Services Equity Researcher Brian Tanquilut joins Yahoo Finance to discuss Walgreens' performance for the quarter and how it can mount a turnaround. Tanquilut lays out one of the big problems with Walgreens and their strategy to implement VillageMD clinics in stores: "The problem with the clinics is that they lose between $1 to $3 million a year on the front end in the first few years. And so, if you just run that math, it is a lot of losses that Walgreens has had to eat over the last couple years, and so as management tries to shore up the balance sheet, improve cash flows, improve profitability, this is one of the big sticking points where you could -- they're looking at, saying, do we really need to invest this much into a physician clinic strategy that is actually not even located in our stores anymore? " For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Nicholas Jacobino
The profitability of Walgreens Boots Alliance core U.S. retail pharmacy business continued to drop in its latest quarter, even as the company continues to put its retail chain at the heart of its future plans. Walgreen’s latest financial results, reported Thursday morning, point to the significant struggles still hobbling those U.S. retail stores. The company’s U.S. retail pharmacy division had adjusted operating income of just $752 million in the three months ending Feb. 29, down 29.5% from the same quarter last year.
Home Depot is acquiring SRS Distribution for $18.25 billion and fiscal second-quarter adjusted earnings at Walgreens beat analysts’ estimates. AMC Entertainment falls sharply after the movie-theater chain files to sell $250 million of stock.